You are here

Conformable Orthopaedic Repair Approach

Award Information
Agency: Department of Defense
Branch: Defense Health Agency
Contract: W81XWH-17-C-0127
Agency Tracking Number: H171-009-0012
Amount: $149,997.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: DHA17-009
Solicitation Number: 2017.1
Solicitation Year: 2017
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-08-15
Award End Date (Contract End Date): 2018-03-14
Small Business Information
1845 West 205th Street
Torrance, CA 90501
United States
DUNS: 153865951
HUBZone Owned: No
Woman Owned: Yes
Socially and Economically Disadvantaged: No
Principal Investigator
 Anya Asanbaeva, Ph.D.
 (310) 320-3088
Business Contact
 Mr. Gordon Drew
Phone: (310) 320-3088
Research Institution

To address the DHA need for a new treatment approach for osteochondral defects that is able to conform to a wide range of complex geometries, Physical Optics Corporation (POC) proposes to develop a new Conformable Orthopaedic Repair Approach (CORA). It is based on minimally invasive delivery of a gel that can be stabilized in situ at the defect site. Specifically, the innovation in our approach is using a gel-based repair and providing appropriate biomimetic cues in the cartilage and bone regions. These innovations will enable CORA to provide a conformable, minimally invasive, non-autologous, and scalable treatment platform requiring minimal surgeon training and existing surgical tools for its implementation. In Phase I, POC will demonstrate the feasibility of CORA in vitro by developing the CORA gel-based repair and assessing the resulting tissue for markers of cartilage and bone. In Phase II, POC plans to test CORA in a relevant animal model and demonstrate its feasibility for intra-operative manipulation and for use in a wide range of osteochondral repair geometries through application of a minimally-invasive procedure.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government